ADAGENE INC. - ADS EACH REPRESENTING 1.25 ORDINAR
1.9400
24-12月-24 13:45:00
15 分の遅延
株式
+0.0600
+3.19%
本日の幅
1.8800 - 2.1000
ISIN
N/A
ソース
NASDAQ
-
07 11 2024 10:01:00 提供 Nasdaq GlobeNewswire
-
09 10 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Adagene to Participate in Investor Conferences in September
29 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update
25 7 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at Investor Conferences in June
22 5 2024 16:45:00 提供 Nasdaq GlobeNewswire
-
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
29 3 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
07 3 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
27 2 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
09 2 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
04 1 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
03 11 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
Adagene to Present at Investor and Scientific Conferences in September
07 9 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
31 8 2023 07:32:21 提供 Nasdaq GlobeNewswire
-
04 5 2023 09:00:01 提供 Nasdaq GlobeNewswire
-
Adagene Announces Updates to its Board of Directors
28 4 2023 07:00:11 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >